Company Data

SELLAS Life Sciences Group Inc.

Ticker
SLS
Current Price
$1.1914 -5.44%
Market Cap
$76.6M
Price Target
Refer to Report
Volume
742.2K
52wk Range
$0.4986 - $1.72
Advanced Market Data

Overview

SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy